Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


AndroGel Generic Settlement Focuses On Co-Promotion Deals

This article was originally published in The Pink Sheet Daily

Executive Summary

Watson and Par will promote Solvay’s testosterone gel until their respective generics launch.

You may also be interested in...

Cephalon Provigil Generics Settlements Under FTC Investigation

FTC seeking information on four deals that postpone generic entry.

Cesamet Launch Will Highlight Longer Duration of Action Vs. Marinol

Valeant will also study the cannabinoid-receptor agonist in combination with other anti-emetics.

Bristol/Sanofi's Plavix Settlement Faces Justice Department Criminal Investigation

Bristol's conduct relating to the settlement with Apotex was "appropriate," CEO Dolan maintains.


Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts